Efsubaglutide Alfa
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery
Shanghai Yinnuo Pharmaceutical Technology Co · Phase 4 · Recruiting · Enrollment 60
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Efsubaglutide Alfa group | n/r | n/r | n/r | n/r | n/r |
| control group | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.